Live Quote · NASDAQAMEDHealthcare· Medical - Care Facilities

Amedisys, Inc.

$100.99 0.01%(+$0.01)
TickerSpark Score
85/100
Strong
73
Valuation
90
Profitability
80
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMED research report →

52-Week Range100% of range
Low
$82.15
Current
$100.99
High
$101.02
Company Overviewwww.amedisys.com

About the company

Amedisys, Inc. , along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health, Hospice, Personal Care, and High Acuity Care.

CEO
Richard M. Ashworth
IPO
1994
Employees
19,000
HQ
Baton Rouge, LA, US

Price Chart

+3.24% · this period
$100.99$92.38$83.78Aug 14Feb 14Aug 15
Valuation
Market Cap
$3.32B
P/E
25.79
P/S
2.73
P/B
2.69
EV/EBITDA
25.35
Div Yield
0.00%
Profitability
Gross Margin
61.83%
Op Margin
7.31%
Net Margin
10.57%
ROE
10.58%
ROIC
3.19%
Growth & Income
Revenue
$2.35B · 5.01%
Net Income
$43.23M · 543.53%
EPS
$1.32 · 540.00%
Op Income
$94.54M
FCF YoY
72.16%
Performance & Tape
52W High
$101.02
52W Low
$82.15
50D MA
$97.76
200D MA
$93.41
Beta
0.90
Avg Volume
517.90K

Get TickerSpark's AI analysis on AMED

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Aug 14, 25Coye Molly Joelsell8,818
Aug 14, 25Klapstein Julie Dsell16,031
Aug 14, 25Kusserow Paul B. K.sell621
Aug 14, 25Kusserow Paul B. K.sell80,602
Aug 14, 25Kusserow Paul B. K.sell439,124
Aug 14, 25Rideout Jeffrey Asell9,335
Aug 14, 25Muscato Nicksell3,067
Aug 14, 25Muscato Nickother3,468
Aug 14, 25Muscato Nicksell272
Aug 14, 25Muscato Nicksell2,040
Coverage · AMED

Our AMED coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on AMED yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate AMED report →
Internal Compare

Similar companies

Peers in the same neighborhood.